Growth Hormone-Releasing Hormone (GHRH) Antagonists Inhibit the Proliferation of Androgen-Dependent and -Independent Prostate Cancers

Autor: Letsch, Markus, Schally, Andrew V., Busto, Rebeca, Bajo, Ana M., Varga, Jozsef L.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America, 2003 Feb 01. 100(3), 1250-1255.

Externí odkaz: https://www.jstor.org/stable/3138318

Effective Treatment of Experimental Androgen Sensitive and Androgen Independent Intraosseous Prostate Cancer With Targeted Cytotoxic Somatostatin Analogue AN-238

Autor: LETSCH, MARKUS, SCHALLY, ANDREW V. ^*, SZEPESHAZI, KAROLY, HALMOS, GABOR, NAGY, ATTILA

Publikováno v: In The Journal of Urology 2004 171(2) Part 1:911-915

Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: Lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.

Autor: Plonowski, Artur, Schally, Andrew V., Letsch, Markus, Krupa, Magdalena, Hebert, Francine, Busto, Rebeca, Groot, Kate, Varga, Jozsef L.

Publikováno v: Prostate; Aug2002, Vol. 52 Issue 3, p173-182, 10p

Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.

Autor: Letsch M; Endocrine, Polypeptide, and Cancer Institute, Veterans Affairs Medical Center and Section of Experimental Medicine, Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA., Schally AV, Szepeshazi K, Halmos G, Nagy A

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2003 Oct 01; Vol. 9 (12), pp. 4505-13.